<?xml version="1.0" encoding="UTF-8"?>
<p>A review of U.S. Vaccine Adverse Event Reporting System (VAERS) data from 2007–2013 found 3.8 SAEs per 100,000 vaccine doses [
 <xref rid="B94-vaccines-07-00179" ref-type="bibr">94</xref>], while a review of passive surveillance data from several non-endemic countries found rates ranging from 1.3 to 5.1 SAE per 100,000 vaccine doses [
 <xref rid="B98-vaccines-07-00179" ref-type="bibr">98</xref>]. The rate is known to increase with age such that 60–69-year old vaccine recipients had a rate of 6.5 SAEs per 100,000 doses while those over 70 years old had a rate of 10.3 [
 <xref rid="B94-vaccines-07-00179" ref-type="bibr">94</xref>]. The three primary SAEs include anaphylaxis (0.2–1.8 per 100,000 doses), neurologic disease (0.1–3.9 per 100,000 doses) and viscerotropic disease (0.07–0.4 per 100,000 doses) due to 17D virus infection of the liver and visceral organs [
 <xref rid="B98-vaccines-07-00179" ref-type="bibr">98</xref>,
 <xref rid="B100-vaccines-07-00179" ref-type="bibr">100</xref>].
</p>
